Ranibizumab

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Product Details
Company Profile

Min.Order :0
Purity: ≥95%

Keywords

RG-6321 Lucentis

Quick Details

Appearance:Colorless to Light Yellow Solution
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:-70 ± 15 °C for long term storage
Transportation:

Superiority:

We provide customized and high-quality Ranibizumab product for your project.

Details:

Ranibizumab is a monoclonal antibody fragment (Fab) which could inhibit angiogenesis via suppressing vascular endothelial growth factor (VEGF) A. In Dec. 2016, it was approved for the treatment of the age-related macular degeneration (AMD) and visual impairment caused by choroidal neovascularization (CNV).

View All